Korsana Biosciences, Inc. (KRSA)

Nasdaq · Pharmaceutical Preparations · Inc. MA

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Korsana Biosciences, Inc.. Most notable: 2026-09-11: Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-03-25Hecht Peter MdirectorA181,8182.75$500,000
2025-03-25Higgins Michael JdirectorA9,0902.75$24,998
2024-11-21Greenspan David Geraldten percent ownerS357,8801.55$554,714

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Korsana Biosciences, Inc. (KRSA): insider trades, federal contracts, lobbying | IP Files